V. Aires, D. Delmas, L. Bachelier, and C. , Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts, Orphanet J Rare Dis, vol.9, p.79, 2014.

T. Aoyama, J. M. Peters, and N. Iritani, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha), J Biol Chem, vol.273, pp.5678-5684, 1998.

A. Boutron, C. Acquaviva, and C. Vianey-saban, Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency, Mol Genet Metab, vol.103, pp.341-348, 2011.

J. H. Choi, H. R. Yoon, G. H. Kim, S. J. Park, Y. L. Shin et al., Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency, Int J Mol Med, vol.19, pp.81-87, 2007.

A. M. Das, S. Illsinger, and T. Lucke, Isolated mitochondrial longchain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene, Clin Chem, vol.52, pp.530-534, 2006.

F. Djouadi and J. Bastin, PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders, J Inherit Metab Dis, vol.31, pp.217-225, 2008.

F. Djouadi, J. P. Bonnefont, and L. Thuillier, Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate, Pediatr Res, vol.54, pp.446-451, 2003.

F. Djouadi, F. Aubey, D. Schlemmer, and J. Bastin, Peroxisome proliferator activated receptor {delta} (PPAR{delta}) agonist but Not PPAR{alpha} corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells, J Clin Endocrinol Metab, vol.90, pp.1791-1797, 2005.

F. Djouadi, F. Aubey, and D. Schlemmer, Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders, Hum Mol Genet, vol.14, pp.2695-2703, 2005.

S. Eaton, T. Bursby, and B. Middleton, The mitochondrial trifunctional protein: centre of a beta-oxidation metabolon?, Biochem Soc Trans, vol.28, pp.177-182, 2000.

A. L. Fletcher, M. E. Pennesi, C. O. Harding, R. G. Weleber, and M. B. Gillingham, Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies, Mol Genet Metab, vol.106, pp.18-24, 2012.

M. B. Gillingham, W. E. Connor, and D. Matern, Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mol Genet Metab, vol.79, pp.114-123, 2003.

S. Gobin-limballe, F. Djouadi, and F. Aubey, Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotypebased therapy, Am J Hum Genet, vol.81, pp.1133-1143, 2007.

M. Haas, V. Vlcek, and P. Balabanov, European medicines agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, Neuromuscul Disord, vol.25, pp.5-13, 2015.

L. Ijlst, J. P. Ruiter, J. M. Hoovers, M. E. Jakobs, and R. J. Wanders, Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene, J Clin Invest, vol.98, pp.1028-1033, 1996.

N. J. Manning, S. E. Olpin, R. J. Pollitt, and J. Webley, 10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts, J Inherit Metab Dis, vol.9, pp.58-68, 1990.

J. Massie, C. Castellani, and W. W. Grody, Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function, Lancet, vol.383, pp.923-925, 2014.

S. E. Olpin, Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability, J Inherit Metab Dis, vol.36, pp.645-658, 2013.

S. E. Olpin, S. Clark, and B. S. Andresen, Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency, J Inherit Metab Dis, vol.28, pp.533-544, 2005.

K. E. Orii, K. O. Orii, and M. Souri, Genes for the human mitochondrial trifunctional protein alpha-and beta-subunits are divergently transcribed from a common promoter region, J Biol Chem, vol.274, pp.8077-8084, 1999.

B. Perez, P. Rodriguez-pombo, M. Ugarte, and L. R. Desviat, Readthrough strategies for therapeutic suppression of nonsense mutations in inherited metabolic disease, Mol Syndromol, vol.3, pp.230-236, 2012.

J. Purevsuren, T. Fukao, Y. Hasegawa, S. Fukuda, H. Kobayashi et al., Study of deep intronic sequence exonization in a Japanese neonate with a mitochondrial trifunctional protein deficiency, Mol Genet Metab, vol.95, pp.46-51, 2008.

A. Sperk, M. Mueller, and U. Spiekerkoetter, Outcome in six patients with mitochondrial trifunctional protein disorders identified by newborn screening, Mol Genet Metab, vol.101, pp.205-207, 2010.

U. Spiekerkoetter, Z. Khuchua, Z. Yue, M. J. Bennett, and A. W. Strauss, General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha-or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover, Pediatr Res, vol.55, pp.190-196, 2004.

J. Sykut-cegielska, W. Gradowska, and D. Piekutowska-abramczuk, Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening, J Inherit Metab Dis, vol.34, pp.185-195, 2011.

R. J. Wanders, J. P. Ruiter, L. Ijlst, H. R. Waterham, and S. M. Houten, The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results, J Inherit Metab Dis, vol.33, pp.479-494, 2010.